NCT06986980 Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
| NCT ID | NCT06986980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Microsporidiosis Intestinal |
| Study Type | OBSERVATIONAL |
| Enrollment | 39 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 39 participants in total. It began in 2025-05-05 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
Eligibility Criteria
Inclusion Criteria: * heart transplant patients diagnosed with intestinal microsporidiosis * diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories) Exclusion Criteria: -patient opposition
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06986980 clinical trial?
This trial is open to participants of all sexes, studying Microsporidiosis Intestinal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06986980 currently recruiting?
Yes, NCT06986980 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06986980 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06986980 clinical trial?
NCT06986980 is sponsored by University Hospital, Clermont-Ferrand. The trial plans to enroll 39 participants.